North Star Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

North Star Investment Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.62K	Sell	226 -24	-10%	-$397	﹤0.01%	1318
2026 Q1	$4.63K	Buy	250 +24	+11%	+$421	﹤0.01%	1209
2025 Q4	$3.52K	Buy	+226	New	+$3.23K	﹤0.01%	1182
2021 Q4	–	Sell	-256	Closed	-$4K	–	1212
2021 Q3	$4K	Hold	256	–	–	﹤0.01%	997
2021 Q2	$4K	Hold	256	–	–	﹤0.01%	969
2021 Q1	$5K	Hold	256	–	–	﹤0.01%	903
2020 Q4	$5K	Sell	256 -297	-54%	-$5.21K	﹤0.01%	874
2020 Q3	$10K	Hold	553	–	–	﹤0.01%	753
2020 Q2	$10K	Hold	553	–	–	﹤0.01%	727
2020 Q1	$8K	Hold	553	–	–	﹤0.01%	758
2019 Q4	$11K	Sell	553 -201	-27%	-$3.85K	﹤0.01%	805
2019 Q3	$13K	Buy	+754	New	+$13K	﹤0.01%	778
2019 Q2	–	Sell	-824	Closed	-$17K	–	867
2019 Q1	$17K	Buy	+824	New	+$16.6K	﹤0.01%	749

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

North Star Investment Management's TAK Position: Q2 2026 in Review

North Star Investment Management reduced its Takeda Pharmaceutical (TAK) stake by 9.6% in Q2 2026, selling an estimated $397 and leaving 226 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

North Star Investment Management first reported a position in TAK in Q1 2019 and has held it in 13 quarters since. The position peaked at $17K in Q1 2019. 380 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

North Star Investment Management held 226 shares of Takeda Pharmaceutical worth $3.62K as of Q2 2026.
North Star Investment Management sold 24 Takeda Pharmaceutical shares in Q2 2026, an estimated $397.
Takeda Pharmaceutical made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1318 holding.
North Star Investment Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
North Star Investment Management's Takeda Pharmaceutical position peaked at $17K in Q1 2019.
380 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.